Super User, Author at BioHealth Innovation - Page 46 of 1257

biotalk disbrow gif

BioTalk with Rich Bendis Podcast

BARDA Director Gary L. Disbrow, Ph.D., Joins Rich Bendis on the BioTalk Podcast

Gary L. Disbrow, Ph.D., Director of the Biomedical Advanced Research and Development…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

B165e489f755c750 600x0 85 files i in Mimetas Jos v4 interviewpage

News

Jos Joore

This interview is part of a series of conversations with the people…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

Cursor and Johns Hopkins spinout Emocha Health closes 6 2M series A for video based medication adherence Fierce Healthcare

News

Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence

Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' decoding='async'/>

Super UserAugust 8, 2022

Glass 2022 08 01 04 30 45 utc

News

What does #USPVerified mean?

What does #USPVerified mean? It means that you can trust that what's…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 8, 2022

News

Immunomic Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ITI-3000 pDNA Vaccine for the Treatment of Merkel Cell Carcinoma Member Discounts – Maryland Tech Council

ROCKVILLE, Md.--(BUSINESS WIRE)--Immunomic Therapeutics, Inc., (“ITI”), a privately-held clinical-stage biotechnology company pioneering…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 8, 2022

Cursor and IPO market in a wait and see period EY Americas IPO leader says

News

IPO market in a ‘wait-and-see period,’ EY Americas IPO leader says

EY Americas IPO Leader Rachel Gerring joins Yahoo Finance Live to discuss…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 8, 2022

News

U.S. Department of Commerce Announces Winners of American Rescue Plan $500 Million Good Jobs Challenge to Expand Employment Opportunities | U.S. Economic Development Administration

WASHINGTON – Today, U.S. Secretary of Commerce Gina Raimondo announced grant awards…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 8, 2022

Emocha Health has patients record videos of themselves taking a medication and asking questions about their treatment, which are then reviewed by a live team to ensure adherence and resolve any issues. CEO Sebastian Seiguer said it's a more effective approach than others that rely on financial incentives or prescription refill rates. (emocha Health)

News

Johns Hopkins spinout Emocha Health closes $6.2M series A for video-based medication adherence | Fierce Healthcare

Emocha Health, a Johns Hopkins University spinout tackling medication adherence with an…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

Cursor and Emergent BioSolutions unveils 7th pandemic CDMO contract this time for Humanigen s late stage antibody hopeful Fierce Pharma

News

Emergent BioSolutions unveils 7th pandemic CDMO contract, this time for Humanigen’s late-stage antibody hopeful | Fierce Pharma

Manufacturing powerhouse Emergent BioSolutions unveiled its seventh COVID-19 CDMO tie-up Monday, this…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

BioTalk logo_226

News

“BioTalk with Rich Bendis” Podcast Featured in BioBuzz Podcasts to Follow Now

In a job market that’s become increasingly competitive and employer-driven, it’s imperative…

<img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' data-src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' data-srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo lazyload' height='70' width='70' loading='lazy' decoding='async' src='data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==' style='--smush-placeholder-width: 70px; --smush-placeholder-aspect-ratio: 70/70;' /><noscript><img alt='Super User' src='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=70&d=mm&r=g' srcset='https://secure.gravatar.com/avatar/bbbbf64ca160a15fd13b4cc1dad93477?s=140&d=mm&r=g 2x' class='avatar avatar-70 photo' height='70' width='70' loading='lazy' decoding='async'/>

Super UserAugust 3, 2022

Previous 1 … 44 45 46 47 48 … 1,257 Next

© 2024 BioHealth Innovation.